SCHEMBL27134411

SCHEMBL27134411

O=Nc1cnc(NC(=O)c2ccccc2NC2CC2)s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ RAB9A P51151 8/20 0.39
▸ NPC1 O15118 7/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ LCK P06239 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ KDR P35968 1/20 0.37
▸ SCD O00767 1/20 0.37
▸ PKM P14618 3/20 0.36
▸ CDK7 P50613 1/20 0.36
▸ CDK9 P50750 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ MLNR O43193 1/20 0.36
▸ NR1I2 O75469 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24073670 0.85 RXFP1 (0.46) KDM4ERAB9ANPC1LCKMAPK14
SCHEMBL27134415 0.83 RAB9A (0.44) STAT3KDM4ERAB9ANPC1MEN1
SCHEMBL24072387 0.82 KDM4E (0.44) STAT3KDM4ERAB9ANPC1MEN1
SCHEMBL27134412 0.81 CCNE1 (0.44) STAT3KDM4ERAB9ANPC1MEN1
SCHEMBL24073673 0.81 KDM4E (0.58) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL24072309 0.81 MEN1 (0.49) STAT3KDM4ERAB9ANPC1MEN1
SCHEMBL24074474 0.81 STAT3 (0.41) STAT3KDM4ERAB9ANPC1MEN1
SCHEMBL24074515 0.81 KAT2B (0.44) STAT3RAB9ANPC1MEN1KMT2A
SCHEMBL24072390 0.80 JAK2 (0.47) STAT3KDM4ERAB9ANPC1MEN1
SCHEMBL24073682 0.80 ALDH1A1 (0.44) STAT3KDM4ERAB9ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 STAT3 3224/4885KDM4E 786/4885RAB9A 3280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback